Veru Inc.

12 clinical trials · Sponsor

Record	Firm	Date
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (NCT07446998)	Veru Inc.	2026-03-26
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt (NCT06282458)	Veru Inc.	2024-04-29
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer (NCT05079360)	Veru Inc.	2023-03-15
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer (NCT05065411)	Veru Inc.	2022-04-11
P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC . (NCT05008510)	Veru Inc.	2021-12-30
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer (NCT04869943)	Veru Inc.	2021-10-12
To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (NCT04843319)	Veru Inc.	2021-06-09
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study (NCT04842747)	Veru Inc.	2021-05-18
COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 (NCT04388826)	Veru Inc.	2020-06-18
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer (NCT03752099)	Veru Inc.	2019-01-18
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer (NCT03646162)	Veru Inc.	2018-09-14

Track Veru Inc. automatically

Every clearance here is in the API, with alerts when new ones post.